Peter Koelblinger Selected Research

Member 2 Subfamily B ATP Binding Cassette Transporter

8/2020	Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.
1/2020	Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Koelblinger Research Topics

Disease

19	Melanoma (Melanoma, Malignant) 04/2024 - 01/2017
9	Neoplasms (Cancer) 12/2023 - 01/2017
3	Neoplasm Metastasis (Metastasis) 12/2023 - 09/2020
1	Inflammation (Inflammations) 05/2023
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Epidermolysis Bullosa 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2017

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 02/2023 - 08/2020
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 01/2017
3	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2023
3	AntibodiesIBA 04/2024 - 01/2019
3	MicroRNAs (MicroRNA)IBA 08/2020 - 11/2019
2	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2020
2	Member 2 Subfamily B ATP Binding Cassette TransporterIBA 08/2020 - 01/2020
2	Cetuximab (Erbitux)FDA Link 01/2019 - 01/2019
2	binimetinibIBA 08/2017 - 01/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023
1	trametinibIBA 12/2023
1	dabrafenibIBA 12/2023
1	Amino Acids FDA Link 07/2022
1	adipic acid (adipate)IBA 07/2022
1	CarbohydratesIBA 07/2022
1	SphingomyelinsIBA 07/2022
1	Triglycerides (Triacylglycerol)IBA 07/2022
1	4-cresol sulfateIBA 01/2021
1	beta-AlanineIBA 01/2021
1	CeramidesIBA 01/2021
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2021
1	Sarcosine (Methylglycine)IBA 01/2021
1	tiglylcarnitineIBA 01/2021
1	talimogene laherparepvecIBA 01/2021
1	Cyclin D1IBA 09/2020
1	Histocompatibility Antigens Class IIBA 08/2020
1	Surface Antigens (Surface Antigen)IBA 08/2020
1	InterferonsIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	Horseradish PeroxidaseIBA 01/2020
1	LuciferasesIBA 01/2020
1	ParaffinIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Bovine Serum AlbuminIBA 01/2020
1	transporter associated with antigen processing (TAP)IBA 01/2020
1	Firefly LuciferasesIBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	tapasinIBA 01/2020
1	Untranslated Regions (Untranslated Region)IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 11/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 11/2019
1	VemurafenibIBA 01/2018
1	encorafenibIBA 01/2018
1	HhAntag691IBA 01/2018
1	IpilimumabIBA 10/2017
1	Phosphotransferases (Kinase)IBA 08/2017

Therapy/Procedure

10	Therapeutics 04/2024 - 01/2017
4	Immunotherapy 05/2023 - 01/2017
1	Ketogenic Diet 07/2022
1	Injections 01/2021
1	Radiotherapy 01/2019